InvestorsHub Logo
Followers 3
Posts 292
Boards Moderated 0
Alias Born 12/21/2022

Re: Tartiaboy post# 275

Tuesday, 03/07/2023 8:58:29 AM

Tuesday, March 07, 2023 8:58:29 AM

Post# of 569
I checked again Tuspetinib on Clinicaltrials.gov. It says "Venetoclax will be given to patients in combo treatment group (Part C) either in 50 mg or 100 mg tablets". Not sure whether they are distinct doses or just dose increments.
https://clinicaltrials.gov/ct2/show/NCT03850574?term=aptose&draw=2&rank=4
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News